Original Research Article
Activity Level and Balance in Subjects with Mild Alzheimer’s DiseasePettersson A.F.a · Engardt M.b · Wahlund L.O.a,c
aGeriatric Clinic Huddinge University Hospital, bDepartment of Physical Therapy, Karolinska Institutet, and cDepartment of Clinical Neuroscience, Occupational Therapy and Elderly Care Research, Karolinska Institutet, Huddinge, Sweden
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
To clarify if Alzheimer’s disease has an impact on activity level and postural control, we examined 17 elderly diagnosed with mild Alzheimer’s disease (MMSE scores 21–29) and 18 age- and gender-matched healthy controls (MMSE scores 27–30) using the Frenchay Activities Index, Bergs Balance Scale, Timed Up & Go and Walking in a Figure of Eight. Mild AD subjects were less active and had lower scores on Bergs Balance Scale, performed Timed Up & Go in longer time and took more steps outside the Figure of Eight, as compared to healthy elderly. This study shows that motor performance is affected already at mild stages of Alzheimer’s disease and also that functional performance other than gait may also be impaired.
© 2002 S. Karger AG, Basel
- McKahn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Task Force on Alzheimer’s disease. Neurology 1984;34:939–944.
- Lopez OL, Wisnieski SR, Becker JT, Boller F, DeKosky ST: Extrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol 1997;54:969–975.
- Funkenstein HH, Albert MS, Cook NR, West CG, Scherr PA, Chown MJ, Pilgrim D, Evans DA: Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer’s disease. Arch Neurol 1993;50:51–56.
- Franssen EH, Reisberg B, Kluger AK, Sinaiko E, Boja C: Cognition-independent neurologic symptoms in normal ageing and probable Alzheimer’s disease. Arch Neurol 1991;48:148–154.
- Goldman WP, Baty JD, Buckles VD, Sahrman S, Morris JC: Motor dysfunction in mildly demented AD individuals without extrapyramidal signs. Neurology 1999;53:956–962.
- Ellis RJ, Caligiuri M, Galasko D, Thal LJ: Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Dis Assoc Disord 1996;10:103–114.
- Morris JC, Rubin EH, Morris EJ, Mandel SA: Senile dementia of the Alzheimer’s type: An important risk factor for serious falls. J Gerontol 1987;42:412–417.
- O’Keeffe ST, Kazeem H, Philpott RM, Playfer JR, Gosney M, Lye M: Gait disturbance in Alzheimer’s disease: A clinical study. Age Ageing 1996;25:313–316.
Kluger A, Gianutsos JG, Golomb J, Ferris SH, George AE, Franssen E, Reisberg B: Patterns of motor impairment in normal ageing, mild cognitive decline, and early Alzheimer’s disease. Gerontol Psychol Sci 1997;52B:28–39.
Richards M, Stern Y, Mayeux R: Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 1993;11:2184–2187.
- Ala TA, Frey WH 2nd: Validation of the NINCDS-ADRDA criteria regarding gait in the clinical diagnosis of Alzheimer’s disease: A clinicopathologic study. Alzheimer Dis Assoc Disord 1995;9:152–159.
- Camicioli R, Howieson D, Lehman S, Kaye J: Talking while walking. Neurology 1997;48:955–958.
- Melton LJ, Beard CM, Kokmen E: Fracture risk in patients with Alzheimer’s disease. J Am Geriatr Soc 1994;42:614–619.
- Folstein MF, Folstein SE, McHugh PR: Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
Morris JC: The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993;43:2412–2414.
- Reisberg B, Ferris SH, de Leon MJ, Crook T: The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136–1139.
- Mendiondo MS, Ashford WJ, Kryscio RJ, Schmitt FA: Modelling Mini Mental State Examination changes in Alzheimer’s disease. Statist Med 2000;19:1607–1616.
- Wade DT, Leigh-Smith J, Langton Hewer R: Social activities after stroke: Measurement and natural history using the Frenchay Activities Index. Int Rehabil Med 1985;7:176–181.
Lundin Olsson L, Jensen J, Wallin K: Bergs balance scale: The Swedish version of the balance scale. Vetenskapligt Suppl 1996;1:16–19.
- Podsiadlo D, Richardson S: The Timed Up & Go, a test of basic functional mobility in frail elderly persons. J Am Geriatr Soc 1991;39:142–148.
Johansson G, Jarnloo G-B: Balance training in 70-year-old women, Phys Ther Pract 1991;7:121–125.
- Frandin K, Sonn U, Svantesson U, Grimby G: Functional balance tests in 76-year-olds in relation to performance, activities of daily living and platform tests. Scand J Rehab Med 1995;27:231–241.
Currier DP: Elements of Research in Physical Therapy, ed 3. Baltimore, Williams & Wilkins, 1990.
Woolacott MH, Tang P-F: Balance control during walking in the older adult: Research and its implications. Phys Ther 1997;6:646–660.
- Alexander NB, Mollo JM, Giordani B, Ashton-Miller JA, Schultz AB, Grunawalt JA: Maintenance of balance, gait patterns and obstacle clearance in Alzheimer’s disease. Neurology 1995;45:908–914.
Camicioli R, Panzer V, Kaye J: Balance in healthy elderly. Arch Neurol 1997;8:976–981.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.